Stephanie Saw: Our review paper on ADCs in NSCLC with AGA is out
Stephanie Saw, Medical Oncologist at National Cancer Center of Singapore, reshared a post by Giannis Mountzios, Director of the 4th Oncology Department and Clinical Trials Unit at Henry Dunant Hospital Center, on X, adding:
“Delighted to share our review paper on ADCs in NSCLC with AGA is out!
Very timely given the anticipated data readouts this year.
Such an honour to be a part of this awesome team, special thanks to Giannis Mountzios and Jordi Remon for leading this.”
Quoting Giannis Mountzios‘s post:
“Biomarker-selected or biomarker-agnostic ADCs for oncogene-addicted NSCLC
Just out in ESMO Cancer Treatment Reviews a comprehensive overview on current landscape, challenges and perspectives.
Grateful to work with a global amazing team, including Stephanie Saw, Lizza Hendriks, Jessica Menis, Tina Cascone, Oscar Arrieta, Jarushka Naidoo, Alfredo Addeo, Solange Peters and senior author Jordi Remon.”
Authors: Giannis Mountzios, et al.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023